Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
21.04
+0.39 (1.89%)
Oct 19, 2026, 9:51 AM EDT - Market open
Tectonic Therapeutic Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Tectonic Therapeutic stock has a consensus rating of "Strong Buy" and an average price target of $71. The average 1-year stock price forecast is 237.45% higher than the current stock price, while the lowest is $26 (+23.57%) and the highest is $93 (+342.02%).
Price Target: $71 (+237.45%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tectonic Therapeutic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Reiterates $60 | Buy | Reiterates | $60 | +185.17% | Oct 16, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $76 | Buy | Maintains | $76 | +261.22% | Oct 14, 2026 |
| UBS | UBS | Hold Initiates $26 | Hold | Initiates | $26 | +23.57% | Oct 11, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $75 | Buy | Maintains | $75 | +256.46% | Oct 1, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $93 | Buy | Reiterates | $93 | +342.02% | Sep 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.77
EPS Next Year
-4.76
from -5.77
EPS and Forward PE are based on non-GAAP adjusted numbers.